文献速递急性肾损伤慢性肾脏病

急性肾损伤恢复期生物标志物可预测长期eGFR下降

Biomarkers During Recovery From AKI and Prediction of Long-term Reductions in Estimated GFR.
PubMed 文献 · Am J Kidney Dis · 2021-10-12

前瞻性队列研究纳入500例急性肾损伤(AKI)存活者,在出院3个月时检测11种血浆生物标志物,评估3年后肾脏病进展风险。sTNFR1、sTNFR2、胱抑素C、NGAL、3个月eGFR和UACR独立相关;包含sTNFR1、sTNFR2、胱抑素C和eGFR的模型AUC为0.79,优化截点后敏感性95%、阴性预测值92%。

要点

  • AKI后3个月检测sTNFR1、sTNFR2、胱抑素C和eGFR可识别长期肾脏病进展低风险者。
  • 该模型作为排除工具时敏感性达95%、阴性预测值达92%。
  • 生物标志物对肾脏病进展的预测重要性超过AKI严重程度或持续时间。

核心结论

  • AKI住院后出院3个月检测血浆生物标志物组合,可识别新发或加重CKD极低风险患者。

研究设计与样本

  • 前瞻性队列研究,纳入单中心2013年5月至2016年5月发生AKI且存活至AKI住院后3年的成人500例,包括有或无基础CKD者。

主要发现

  • sTNFR1、sTNFR2、胱抑素C、NGAL、3个月eGFR和UACR与肾脏病进展独立相关,且比AKI严重程度或持续时间更重要。
  • 包含sTNFR1、sTNFR2、胱抑素C和eGFR的多变量模型区分肾脏病进展的AUC为0.79(95%CI 0.70-0.83)。
  • 优化截点以最大化排除效用后,模型敏感性为95%,阴性预测值为92%。

关键数值与推荐

  • 肾脏病进展定义为AKI发生后3年时eGFR较基线下降≥25%且CKD分期恶化。
  • 预测模型包含sTNFR1、sTNFR2、胱抑素C和eGFR,AUC 0.79(95%CI 0.70-0.83)。

临床怎么用

  • AKI后3个月可检测sTNFR1、sTNFR2、胱抑素C和eGFR,辅助识别长期肾脏病进展低风险患者。
  • 该模型作为排除工具时敏感性和阴性预测值较高,但需外部验证后用于临床。

局限性

  • 缺乏外部验证队列。
  • 分析仅限AKI后存活3年的患者。
  • 研究人群混合了有和无基线CKD的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: The effects of acute kidney injury (AKI) on long-term kidney function, cardiovascular disease, and mortality are well documented. We aimed to identify biomarkers for the estimation of risk of new or worsening chronic kidney disease (CKD) following AKI. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: Adults from a single clinical center who experienced AKI between May 2013 and May 2016 and survived until 3 years after the hospitalization during which AKI occurred. Participants included those with and without preexisting CKD. PREDICTORS: Panel of 11 plasma biomarkers measured 3 months after hospitalization. OUTCOME: Kidney disease progression, defined as a≥25% decrease in estimated glomerular filtration rate (eGFR) combined with worsening CKD stage, assessed 3 years after the occurrence of AKI. ANALYTICAL APPROACH: Associations between biomarkers and kidney disease progression were evaluated in multivariable logistic regression models. Importance of predictor variables was assessed by constructing multiple decision trees, with penalized least absolute shrinkage and selection operator logistic regression for variable selection used to produce multivariable models. RESULTS: A total of 500 patients were studied. Soluble tumor necrosis factor receptor (sTNFR) 1, sTNFR2, cystatin C, neutrophil gelatinase-associated lipocalin, 3-month eGFR, and urinary albumin-creatinine ratio were independently associated with kidney disease progression and were more important than AKI severity or duration. A multivariable model containing sTNFR1, sTNFR2, cystatin C, and eGFR discriminated between those with and without kidney disease progression (area under the curve, 0.79 [95% CI, 0.70-0.83]). Optimizing the cutoff point to maximize utility as a "rule-out" test to identify those at low risk increased the sensitivity of the model to 95% and its negative predictive value to 92%. LIMITATIONS: Lack of external validation cohort. Analyses limited to patients who survived for 3 years after AKI. Mixed population of patients with and without baseline CKD. CONCLUSIONS: A panel of plasma biomarkers measured 3 months after discharge from a hospitalization complicated by AKI provides a potential opportunity to identify patients who are at very low risk of incident or worsening CKD. Further study is required to determine its clinical utility through independent prospective validation.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Wilson M, Packington R, Sewell H, et al. Biomarkers During Recovery From AKI and Prediction of Long-term Reductions in Estimated GFR. Am J Kidney Dis. 2021. PMID: 34653541. doi:10.1053/j.ajkd.2021.08.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。